학술논문

Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial
Document Type
Article
Source
In: JAMA Oncology. (JAMA Oncology, 15 February 2024, 10(2):185-192)
Subject
Language
English
ISSN
23742445
23742437